Conversion from Sandimmune to Neoral in stable heart transplant recipients.
Pethig
K
K
Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Germany.
Ruhparwar
A
A
Korn
A
A
Christians
U
U
Wahlers
T
T
D000284:Administration, Oral; D001682:Biological Availability; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004304:Dosage Forms; D004305:Dose-Response Relationship, Drug; D005260:Female; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine